Improving Colonoscopy Diagnostic Reliability in Viet Nam: Bowel Preparation, Cecal Intubation and Lesion Detection Performance
MEASUREMENT, LEARNING & IMPROVEMENTDIAGNOSTIC SAFETY & RISK MANAGEMENT
11/5/202621 min read


Improving Colonoscopy Diagnostic Reliability in Viet Nam: Bowel Preparation, Cecal Intubation and Lesion Detection Performance
A colonoscopy report may state that the examination was completed, the cecum was reached, and no significant abnormalities were found. For the patient, this can provide considerable reassurance. But what if part of the colonic mucosa was obscured by residual stool? What if a subtle, flat lesion in the right colon was difficult to distinguish from surrounding tissue? Or what if the colonoscope reached the cecum, but the subsequent inspection was not sufficiently thorough?
A completed colonoscopy is not necessarily a high-quality colonoscopy.
This distinction matters because colonoscopy plays an important role in detecting colorectal cancer and identifying precancerous lesions that may be removed before malignant transformation. Its effectiveness depends on adequate bowel preparation, examination of the relevant anatomy, careful mucosal inspection, and the ability to recognize clinically important abnormalities.
International professional societies have increasingly emphasized measuring these aspects of performance. The objective is not simply to perform more procedures or document successful completion. It is to reduce potentially avoidable missed lesions and improve the reliability of the findings used to guide patient care.
The 2024 quality indicator update from the American Society for Gastrointestinal Endoscopy (ASGE) and the American College of Gastroenterology (ACG), followed by the 2025 US Multi-Society Task Force recommendations on bowel preparation, provides an updated framework for assessing colonoscopy quality.
An important development for Viet Nam followed in September 2026, when the Vietnam Interventional Gastroenterological Endoscopy Society published expert consensus statements on bowel preparation for colonoscopy.
Together, these publications provide an opportunity for Vietnamese healthcare organizations to examine whether their colonoscopy services consistently achieve the conditions needed for reliable lesion detection, appropriate clinical interpretation, and subsequent management.
Why Colonoscopy Quality Matters for Diagnostic Reliability
Colonoscopy differs from many diagnostic examinations because the same procedure can identify a lesion, obtain tissue for histopathological assessment, and allow removal of certain precancerous abnormalities. These capabilities make colonoscopy an important component of colorectal cancer prevention.
However, the quality of an examination can vary according to patient preparation, technical conditions, lesion characteristics, and the performance of the endoscopist.
Conventional adenomas are well-established precursors of colorectal cancer. Sessile serrated lesions represent another clinically important group of precancerous abnormalities, often occurring in the proximal colon and sometimes presenting with subtle appearances that make recognition difficult.
A lesion may be missed because it is obscured by residual bowel contents, hidden behind a mucosal fold, relatively flat, or difficult to distinguish from surrounding mucosa. Other limitations may arise when the examination cannot be completed safely, when a lesion is incompletely removed, or when important procedural findings are inadequately documented.
The clinical importance of these problems is reflected in research on post-colonoscopy colorectal cancer (PCCRC).
PCCRC generally refers to colorectal cancer diagnosed after an earlier colonoscopy in which cancer was not identified, within a defined subsequent period. The precise definition and time window depend on the research or quality assessment framework used.
Some cases may be associated with lesions that were not recognized or were incompletely removed. Others may involve biological characteristics, disease progression, or circumstances that were not reasonably predictable during the earlier examination.
A subsequent cancer diagnosis does not automatically establish that the original colonoscopy was performed incorrectly or that the outcome was preventable. Nevertheless, these cases offer opportunities to examine whether bowel preparation, anatomical completeness, lesion recognition, resection, or subsequent follow-up could have been improved.
The 2024 ASGE/ACG quality indicator update identifies several measures that help endoscopy services understand these different aspects of performance. Among the most relevant are bowel preparation adequacy, cecal intubation rate, adenoma detection rate, sessile serrated lesion detection rate, and adherence to appropriate screening and surveillance intervals.
These indicators address different dimensions of quality. Good performance in one does not automatically compensate for weaknesses in another.
Bowel Preparation: The Foundation of Reliable Mucosal Inspection
The endoscopist can only examine mucosa that is sufficiently visible. Residual stool, opaque fluid, or adherent material may conceal lesions, particularly smaller or flatter abnormalities. Inadequate preparation can also make the procedure more difficult, prolong the examination, and increase the likelihood that another colonoscopy will be needed.
Bowel preparation therefore has a direct influence on diagnostic reliability.
The US Multi-Society Task Force on Colorectal Cancer updated its consensus recommendations for optimizing bowel preparation in 2025. The guidance defines adequate preparation in practical terms: the colon should be sufficiently clean to allow an appropriate standard screening or surveillance interval to be assigned based on the examination findings.
This definition is important because visual cleanliness is not an end in itself. The clinically relevant question is whether the preparation provided conditions suitable for reliable mucosal assessment and subsequent decision-making.
The 2025 recommendations favor split-dose bowel preparation, in which the prescribed regimen is divided so that part of the preparation is taken closer to the examination.
For appropriately selected patients, lower-volume regimens may provide effective cleansing with improved tolerability. Same-day preparation is an acceptable alternative for afternoon colonoscopy, whereas it is generally considered a less favorable option for morning procedures.
The choice of regimen should reflect the patient's clinical circumstances, relevant medical conditions, medication use, previous preparation experience, and the safety profile of the selected product.
Patients with renal impairment, heart failure, electrolyte disturbances, significant constipation, or other relevant conditions may require additional assessment when selecting a preparation strategy.
The recommendations should not be interpreted as requiring the same product, volume, or dosing schedule for every patient.
Patient communication is also essential. Written instructions alone may be insufficient when patients have difficulty understanding dose timing, dietary restrictions, or the importance of completing the prescribed regimen.
Healthcare organizations can improve preparation reliability by providing understandable instructions, allowing patients to clarify uncertainties, and identifying individuals who may need additional support.
Preparation quality should not be regarded solely as the patient's responsibility. Scheduling arrangements, instruction quality, access to suitable products, and the ability to obtain timely advice can all influence the outcome.
The objective is to provide a preparation process that is safe, feasible, and likely to achieve adequate cleansing for the individual patient.
Assessing Bowel Preparation With Consistent Criteria
A quality improvement program needs a consistent method for determining whether bowel preparation was adequate.
The Boston Bowel Preparation Scale (BBPS) is a widely used system that evaluates cleansing in three colonic segments: the right colon, transverse colon, and left colon. Each segment receives a score from 0 to 3, producing a total score between 0 and 9.
An important characteristic of the BBPS is that scoring occurs after washing and suctioning performed during withdrawal. This allows the score to reflect the quality of mucosal visualization actually achieved rather than the initial appearance of the bowel.
The 2024 ASGE/ACG quality indicators describe adequate preparation as a BBPS score of at least 2 in each of the three segments, or an equivalent documented assessment indicating that cleansing was adequate.
The segment-level requirement matters. For example, a total BBPS score of 6 could represent scores of 2, 2, and 2, indicating adequate visualization across all three segments. The same total could result from scores of 3, 3, and 0, where one segment remains inadequately assessed.
These examinations are not equivalent despite having the same total score.
Recording segment-level preparation quality can therefore provide more meaningful information than a general statement such as satisfactory preparation. Where an endoscopy unit adopts BBPS or another validated assessment system, personnel should be trained to apply it consistently.
The assessment should also influence the clinical conclusions drawn from the examination.
A colonoscopy performed with inadequate preparation should not automatically be treated as equivalent to an adequately performed negative examination when determining future screening or surveillance.
The 2025 US Multi-Society Task Force recommendations advise repeating colonoscopy within 12 months when preparation is inadequate for screening or surveillance examinations.
A different consideration applies when the original colonoscopy followed an abnormal noncolonoscopic colorectal cancer screening test. In that situation, the guidance recommends repeating the examination as soon as possible, generally within approximately three months.
These recommendations illustrate why the appropriate timing of another examination depends on the original indication and the potential consequences of incomplete assessment.
They are professional recommendations for defined circumstances, not universal legal deadlines that override individual clinical judgment or applicable Vietnamese requirements.
Measuring Bowel Preparation Quality Without Distorting Performance
The 2024 ASGE/ACG quality indicators recommend a bowel preparation adequacy rate of at least 90% for outpatient colonoscopy. The 2025 US Multi-Society Task Force recommendations also establish a target of at least 90% at both the individual endoscopist and endoscopy unit levels.
However, a high reported percentage is meaningful only when the eligible population and calculation method are properly defined.
One important issue concerns examinations canceled because preparation was clearly inadequate before the colonoscope was inserted.
The 2025 recommendations advise including these cases when calculating bowel preparation adequacy rates at the relevant endoscopist and unit levels. Excluding them may make performance appear better without reflecting the actual reliability of the preparation process.
For example, a service may report excellent preparation quality among completed colonoscopies while overlooking patients whose examinations were canceled or postponed because cleansing was inadequate.
A dependable measurement system should capture these experiences rather than focusing exclusively on procedures that proceeded to completion.
The unit should establish clear criteria for eligible cases, preparation assessment, and classification of canceled or incomplete examinations.
Performance also needs to be interpreted in relation to the patients receiving care. Inpatients, individuals with previous inadequate preparation, patients with significant constipation, and those with particular medical conditions may experience different challenges.
These differences should guide improvement efforts rather than encourage the exclusion of more complex patients.
The purpose of measuring preparation quality is to identify where the process can be improved, not to produce a favorable percentage by changing which patients are counted.
Cecal Intubation: Confirming Anatomical Completeness
Cecal intubation is an important indicator of whether colonoscopy reaches its intended anatomical extent.
It involves advancing the colonoscope into the cecum and identifying the relevant landmarks that establish the proximal end of the examination. The appendiceal orifice and ileocecal valve are particularly important anatomical landmarks.
The 2024 ASGE/ACG quality indicators recommend a cecal intubation rate of at least 95% among eligible colonoscopies, supported by appropriate photographic documentation.
The measure concerns patients undergoing colonoscopy with an intact colon, subject to the relevant eligibility and exclusion criteria.
This matters because a statement that the cecum was reached is not necessarily equivalent to verifiable evidence of complete insertion. Photographs of the appropriate landmarks can help confirm that the intended anatomical extent was reached.
However, cecal intubation should not be pursued regardless of patient safety.
Significant obstruction, severe inflammation, difficult anatomy, or other clinical circumstances may make further advancement inappropriate. A decision to stop the procedure for a justified clinical reason should be evaluated within the relevant clinical context rather than automatically classified as poor professional performance.
The quality indicator therefore requires appropriate eligibility definitions, exclusion criteria, and documentation.
Successful cecal intubation establishes that the colonoscope reached the intended anatomical location. It does not demonstrate that every segment of the colonic mucosa was adequately inspected during withdrawal.
An endoscopist may reach the cecum but still fail to identify a subtle lesion if bowel preparation, visualization, or inspection technique is inadequate.
Cecal intubation should consequently be interpreted alongside preparation quality and lesion detection performance.
Adenoma Detection Rate: Understanding an Important Performance Indicator
Adenoma detection rate (ADR) is one of the most established colonoscopy quality indicators because of its association with subsequent colorectal cancer risk.
ADR generally measures the proportion of eligible colonoscopies in which at least one conventional adenoma is detected and confirmed by histopathology. It is not simply the number of polyps identified or removed.
The 2024 ASGE/ACG update increased the recommended minimum ADR threshold to 35%.
However, this threshold applies to a defined measurement population.
The updated indicator includes eligible outpatient colonoscopies among patients aged 45 years or older performed for screening, surveillance, or diagnostic indications, with specified exclusions.
These exclusions include colonoscopies following positive noncolonoscopic colorectal cancer screening tests, certain hereditary cancer syndromes, inflammatory bowel disease, and procedures performed for treatment of known neoplasia.
The distinction is important because adenoma prevalence differs substantially between patient groups.
For colonoscopies performed after a positive noncolonoscopic screening test, including fecal immunochemical testing or multitarget stool DNA testing, the 2024 ASGE/ACG guidance identifies a separate ADR threshold of at least 50%.
These procedures should not simply be combined with the standard ADR measurement population.
The eligible population must therefore be clearly defined before performance is calculated or compared.
A service performing colonoscopy primarily for symptomatic patients may have a different case mix from one providing organized colorectal cancer screening. Patient age, sex, clinical indications, previous screening history, and referral patterns can also influence observed detection rates.
For this reason, raw ADR percentages should not be compared without considering the underlying population and measurement definitions.
The evidence linking ADR with post-colonoscopy colorectal cancer supports its value as a quality indicator. However, an individual patient's outcome cannot be predicted from an endoscopist's ADR alone.
A high ADR does not establish that every examination was satisfactory. Conversely, a low rate requires appropriate review before conclusions are drawn about individual professional competence.
ADR is most useful when calculated consistently across a sufficiently defined group of examinations and supported by reliable linkage to histopathology results.
Sessile Serrated Lesion Detection: A Different Diagnostic Challenge
Sessile serrated lesions (SSLs) are particularly important because their appearance can make them difficult to recognize during routine colonoscopy.
Unlike many conventional adenomas that protrude more clearly from surrounding mucosa, SSLs may be relatively flat, pale, or covered by a thin layer of mucus. They are frequently found in the proximal colon, including the cecum and ascending colon.
These characteristics may make them less conspicuous when bowel preparation is imperfect or mucosal inspection is insufficient.
The 2024 ASGE/ACG update introduced sessile serrated lesion detection rate (SSLDR) as a priority quality indicator, with a recommended minimum threshold of at least 6% in the defined eligible population.
SSLDR measures the proportion of eligible colonoscopies in which at least one sessile serrated lesion is removed and documented by histopathology.
The indicator applies to an appropriately defined population aged 45 years or older undergoing screening, surveillance, or diagnostic colonoscopy, with exclusions similar to those used for standard ADR measurement.
It should not be confused with a general serrated polyp detection rate that includes all serrated or hyperplastic lesions without appropriate classification.
A service may achieve an acceptable ADR while demonstrating relatively low SSL detection. This is why ADR and SSLDR provide complementary information.
Conventional adenoma detection alone may not reveal difficulties in recognizing the subtler morphology of serrated lesions.
Histopathological interpretation is also relevant.
Distinguishing sessile serrated lesions from hyperplastic polyps can be challenging, and variation in classification may influence the reported SSLDR.
An unexpectedly low SSLDR should therefore prompt consideration of both endoscopic detection practices and the consistency of pathology assessment.
Collaboration between endoscopists and pathologists may help determine whether a performance pattern reflects lesion recognition, specimen handling, histopathological classification, or characteristics of the patient population.
This illustrates how colonoscopy quality depends on more than what is seen during the procedure. The diagnostic process also requires accurate tissue assessment and appropriate integration of endoscopic and pathological findings.
Withdrawal Inspection: Why Time Alone Is Not Enough
The withdrawal phase is a critical opportunity for systematic inspection of the colonic mucosa. Research has identified associations between withdrawal inspection time and lesion detection performance.
The 2024 ASGE/ACG quality indicators increased the recommended minimum average withdrawal time to eight minutes for a defined group of normal colonoscopies in patients aged 45 years or older.
This recommendation is frequently misunderstood.
It does not require every withdrawal to last exactly eight minutes, nor does it establish that a longer procedure automatically provides better diagnostic quality.
The measure concerns average withdrawal time in appropriately selected examinations without biopsy, polypectomy, or other interventions that would affect interpretation of inspection time.
The relevant measurement population also excludes specified groups, including patients undergoing colonoscopy following positive noncolonoscopic screening tests, those with certain hereditary cancer syndromes or inflammatory bowel disease, and procedures for treatment of known neoplasia.
A longer withdrawal period may provide more opportunity for careful examination, but the quality of the inspection remains essential.
The endoscopist must maintain adequate visualization, examine mucosa behind folds, recognize subtle abnormalities, and respond appropriately when additional cleaning or inspection is needed.
Withdrawal time is therefore a supporting process indicator rather than a substitute for ADR or SSLDR.
An endoscopy unit with low lesion detection performance and short average withdrawal times may have a reason to examine its inspection practices.
Conversely, satisfactory withdrawal times combined with low detection performance should prompt broader review rather than the assumption that further increasing time alone will resolve the problem.
Relevant factors may include bowel preparation, lesion recognition, case mix, equipment capabilities, endoscopist experience, and pathology reporting.
For quality improvement, withdrawal time should help assess whether the examination provides an appropriate opportunity for careful inspection, rather than become a target pursued independently of diagnostic performance.
The Diagnostic Process Continues After a Lesion Is Found
The value of colonoscopy does not end when a lesion is identified.
Where a lesion is removed or sampled, histopathological assessment may influence the subsequent diagnosis, risk classification, and surveillance recommendation.
Reliable linkage between colonoscopy reports and pathology findings is also necessary for accurate measurement of ADR and SSLDR. A detection indicator based on histologically confirmed lesions cannot be calculated reliably if endoscopic and pathological records are not appropriately connected.
The quality of lesion removal is another consideration.
Identifying a lesion does not necessarily mean that it has been completely removed. The method of resection, lesion size and morphology, and completeness of removal may have important implications for subsequent care.
The 2024 ASGE/ACG update includes additional quality indicators addressing documentation of resected lesions and appropriate resection techniques for selected polyp sizes.
These measures reinforce the distinction between detecting an abnormality and managing it effectively.
Surveillance recommendations also depend on more than whether a polyp was present. Relevant considerations may include lesion number, size, histological type, dysplasia, completeness of removal, bowel preparation quality, and whether the examination reached its intended extent.
The 2024 ASGE/ACG framework identifies adherence to appropriate screening and surveillance intervals as another priority quality indicator.
Unnecessarily short intervals can expose patients to avoidable procedures, costs, and procedural risks. Intervals that are too long may delay the identification of clinically important abnormalities.
Where pathology results are not yet available, an initial recommendation may need to be reviewed after the final histopathological assessment.
Healthcare organizations should have appropriate processes for incorporating those findings into subsequent care and communicating clinically meaningful changes.
A technically successful colonoscopy is only one part of a dependable diagnostic pathway.
Learning From Post-Colonoscopy Colorectal Cancer
Post-colonoscopy colorectal cancer provides an opportunity to examine the longer-term reliability of colonoscopy services. However, individual cases require careful interpretation.
A colorectal cancer diagnosed after an earlier colonoscopy may be associated with a lesion that was not recognized, inadequate visualization, incomplete removal, or biological factors that were not reasonably predictable during the original examination.
The time between examinations, quality of preparation, anatomical completeness, previous findings, pathology results, and surveillance recommendations all influence the assessment.
It would be inappropriate to classify every subsequent cancer diagnosis as evidence of a preventable diagnostic error.
Nevertheless, structured review can identify opportunities for improvement.
When a relevant case is identified, the organization may examine the earlier colonoscopy report, photographic documentation, bowel preparation assessment, procedural completeness, pathology findings, and recommended follow-up interval.
Reviewers should distinguish limitations that were recognized and appropriately managed from potential weaknesses in the original diagnostic process.
Recurring cases involving proximal colon lesions, for example, may justify closer examination of right-colon preparation quality and sessile serrated lesion detection.
Other cases may reveal problems in documenting incomplete examinations, confirming resection outcomes, or communicating surveillance recommendations after pathology review.
The assessment should consider what was known and reasonably assessable at the time rather than judging the earlier procedure solely in light of the eventual diagnosis.
The purpose is to identify credible opportunities for improving care, not to assume that every unfavorable outcome was avoidable.
A Relevant Development in Viet Nam: The 2026 Bowel Preparation Consensus
International guidance provides an important foundation for colonoscopy quality improvement, but implementation needs to account for the healthcare context in which services are delivered.
A particularly relevant development for Viet Nam was published online in Clinical Endoscopy on September 22, 2026.
Nguyen and colleagues reported consensus statements developed by the Vietnam Interventional Gastroenterological Endoscopy Society concerning bowel preparation for colonoscopy.
The authors recognized that international recommendations may not fully reflect local clinical circumstances and that nationally adapted professional guidance could support greater consistency.
The consensus development process involved 45 Vietnamese gastroenterologists and used a two-round modified Delphi approach.
A steering committee developed the initial statements using international guidance and relevant published evidence while considering the Vietnamese healthcare context.
Consensus was defined as agreement by at least 80% of participating experts, and nine statements were finalized. The development process was informed by the AGREE II framework to support methodological consistency and transparency.
This publication represents an important contribution to professional discussion in Viet Nam.
It reflects an effort to adapt international evidence to local practice rather than assume that recommendations developed in another healthcare system can be implemented without modification.
However, the status of the publication should be understood accurately.
It represents expert consensus developed by a professional society, not a legally binding national technical regulation issued by the Ministry of Health.
Its publication also does not establish that all Vietnamese endoscopy facilities have implemented the recommendations or achieved a particular level of bowel preparation quality.
The consensus provides a foundation for local adaptation, professional education, and future evaluation.
For healthcare organizations, considering this locally developed guidance alongside established international quality indicators may support more consistent preparation practices and performance measurement.
Implementation should still reflect the service's patient population, clinical indications, staff competence, authorized activities, equipment, and available resources.
Applying Quality Indicators Within Viet Nam's Legal Framework
Colonoscopy services in Viet Nam operate within the legal framework governing medical examination and treatment, professional qualifications, healthcare facility activities, and technical procedures.
The Law on Medical Examination and Treatment No. 15/2023/QH15, effective January 1, 2024, and Decree No. 96/2023/ND-CP provide important legal foundations.
Healthcare organizations must consider the professional activities they are authorized to perform, the qualifications and practice scope of their personnel, and applicable requirements for delivering medical examination and treatment services.
Circular No. 23/2024/TT-BYT establishes the list of medical examination and treatment techniques.
Circular No. 25/2026/TT-BYT, issued on June 30, 2026, amended certain provisions of Circular No. 23/2024/TT-BYT.
Although Circular No. 25/2026/TT-BYT generally took effect on August 15, 2026, its Article 3 concerning the list of medical examination and treatment techniques took effect earlier, on July 1, 2026, under the specific provision in Article 6.
The consolidated technical list is reflected in Consolidated Document No. 13/2026/VBHN-TT-BYT, dated July 30, 2026.
Under the amended transitional provisions, the technical list in Appendix 01 applies through December 31, 2027, while Appendix 02 applies from January 1, 2028.
These instruments are relevant when healthcare organizations determine the technical procedures they are authorized to perform and the applicable regulatory arrangements.
However, a technical procedure list should not be confused with a complete quality assessment framework for colonoscopy performance.
Similarly, international quality indicators developed by ASGE, ACG, or other professional organizations should not automatically be presented as legally binding requirements for every healthcare facility in Viet Nam.
An ADR threshold developed for a particular US measurement population may provide a useful reference for local improvement, but its adoption and interpretation require consideration of patient characteristics, clinical indications, data quality, and professional circumstances.
The distinction between professional guidance, voluntary quality improvement benchmarks, accreditation commitments, and legally enforceable obligations is important.
The 2026 Vietnamese consensus on bowel preparation contributes to professional standardization without automatically replacing regulations issued by competent authorities.
Healthcare organizations should therefore distinguish the legal requirements applicable to their services from additional professional and quality improvement measures adopted to strengthen performance.
Protecting Patient Information in Quality Review
Colonoscopy quality monitoring may involve reviewing identifiable patient information, endoscopic images, pathology findings, procedural reports, and subsequent clinical outcomes.
Viet Nam's Law on Personal Data Protection No. 91/2025/QH15 and Decree No. 356/2025/ND-CP took effect on January 1, 2026.
Healthcare organizations should assess the applicable legal requirements concerning lawful processing, confidentiality, authorized access, information security, and the sharing or transfer of personal data.
Internal quality assessment, external professional consultation, research, and educational activities may involve different purposes. The legal basis, applicable consent requirements, exceptions, and safeguards should be considered according to the nature of each activity.
Where clinically relevant information is linked across endoscopy and pathology systems, organizations should preserve its accuracy and availability while limiting access to appropriately authorized personnel.
Reliable quality measurement depends on trustworthy information, but it must also respect patient confidentiality and applicable data protection requirements.
Measuring Colonoscopy Quality as a Connected System
An endoscopy service can begin improving diagnostic reliability with a focused group of indicators.
Bowel preparation adequacy describes the conditions under which mucosal inspection takes place. Cecal intubation rate assesses whether the examination reaches its intended anatomical extent in eligible procedures. ADR and SSLDR measure different aspects of lesion detection performance.
Average withdrawal time, calculated for the appropriate examination population, provides information about the opportunity for careful inspection.
Adherence to recommended screening and surveillance intervals helps determine whether procedural and pathology findings are translated into appropriate subsequent care.
These indicators are most useful when considered together.
A service with high cecal intubation but low ADR may need to examine its lesion recognition and inspection practices. A service with satisfactory ADR but low SSLDR may need to focus on detecting subtle proximal colon lesions and reviewing the consistency of pathology classification.
Low bowel preparation adequacy may contribute to incomplete examinations, missed lesions, and earlier repeat procedures.
Unexpected variation in surveillance recommendations may indicate that important procedural or histopathological information is not being incorporated consistently into clinical decisions.
These patterns cannot be understood from a single performance score. They require appropriately defined measurements, reliable data, and professional interpretation.
Healthcare organizations should establish clear inclusion and exclusion criteria for each indicator, identify the relevant data sources, and review performance at suitable intervals.
Case volume and statistical uncertainty also matter.
A percentage calculated from a small number of examinations may fluctuate substantially. It should not automatically be treated as a reliable measure of an individual endoscopist's competence.
Performance review should also recognize differences in patient populations and the potential effects of case mix.
The purpose of measurement is to identify opportunities for improvement, not to encourage selective patient acceptance, incomplete reporting, or unnecessary procedures intended to improve apparent performance.
Turning Performance Information Into Practical Improvement
A quality monitoring program becomes valuable when it leads to meaningful changes in clinical practice.
Consider an endoscopy unit where bowel preparation adequacy consistently falls below the organization's accepted target.
The initial response might be to provide longer written instructions. However, this may not address the reasons patients are arriving with inadequate preparation.
Some may receive instructions too late. Others may misunderstand the timing of prescribed doses or have difficulty completing the preparation.
Patients with constipation, previous preparation failure, or relevant medical conditions may require more individualized arrangements.
A structured review can identify which factors contribute most to inadequate preparation in that particular service.
The organization can then introduce targeted interventions, such as improving pre-procedure communication, reviewing preparation selection, identifying higher-risk patients earlier, or strengthening appointment coordination.
Subsequent measurement can establish whether these changes improve preparation adequacy.
A different unit may achieve satisfactory bowel preparation and cecal intubation rates while demonstrating unexpectedly low sessile serrated lesion detection.
In that situation, additional instructions about bowel preparation may not address the principal problem. Improvement may instead require attention to proximal colon inspection, recognition of subtle lesion morphology, and collaboration with pathologists.
The response should match the weakness identified.
Individual endoscopists benefit from reliable feedback about their performance and opportunities for professional discussion. Quality teams need sufficient data to distinguish meaningful patterns from variation caused by small samples or differences in patient characteristics.
Clinical leadership should support appropriate training, technical review, professional development, and corrective action while maintaining patient safety.
A sustainable quality improvement process is not one that merely produces favorable statistics. It is one that helps the organization recognize limitations, understand their causes, and determine whether changes in practice actually improve the reliability of care.
Strengthening Colonoscopy Reliability as Part of Diagnostic Excellence
Colonoscopy quality cannot be established by a single statement that the procedure was completed successfully.
A reliable examination requires adequate bowel preparation, appropriate anatomical completeness, careful mucosal inspection, effective recognition of clinically important lesions, and sufficient documentation to guide subsequent management.
The international evidence available in 2026 provides a useful framework for assessing these dimensions.
The 2024 ASGE/ACG quality indicators identify performance measures relevant to colorectal cancer detection and prevention. The 2025 US Multi-Society Task Force recommendations strengthen the approach to bowel preparation and its measurement. The September 2026 Vietnamese expert consensus adds a locally relevant professional contribution.
For healthcare organizations in Viet Nam, the opportunity is not simply to perform more colonoscopies or introduce more advanced equipment. It is to understand whether the procedures being performed consistently provide reliable opportunities to detect clinically important abnormalities.
A documented cecal intubation does not compensate for inadequate mucosal visualization. A satisfactory adenoma detection rate does not eliminate the need to examine sessile serrated lesion detection. A technically completed procedure does not remove the responsibility to recognize limitations and provide appropriate subsequent recommendations.
Diagnostic excellence in colonoscopy is not demonstrated by procedural completion alone. It depends on whether the examination provides a reliable assessment of the colonic mucosa, whether clinically significant lesions are appropriately identified and managed, and whether healthcare organizations can use meaningful performance information to improve the quality of care.
Selected References and Regulatory Sources
Rex DK, Anderson JC, Butterly LF, et al. Quality Indicators for Colonoscopy. Gastrointestinal Endoscopy. 2024;100(3):352–381. DOI: 10.1016/j.gie.2024.04.2905.
Rex DK, Anderson JC, Butterly LF, et al. Quality Indicators for Colonoscopy. American Journal of Gastroenterology. 2024;119(9):1754–1780. DOI: 10.14309/ajg.0000000000002972.
Jacobson BC, Anderson JC, Burke CA, et al. Optimizing Bowel Preparation Quality for Colonoscopy: Consensus Recommendations by the US Multi-Society Task Force on Colorectal Cancer. Gastrointestinal Endoscopy. 2025;101(4):702–732. DOI: 10.1016/j.gie.2025.02.010.
Jacobson BC, Anderson JC, Burke CA, et al. Optimizing Bowel Preparation Quality for Colonoscopy: Consensus Recommendations by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2025;168(4):798–829. DOI: 10.1053/j.gastro.2025.02.002.
Nguyen HN, Nguyen VK, Ho HN, et al. Consensus Statements From the Vietnam Interventional Gastroenterological Endoscopy Society on Bowel Preparation for Colonoscopy. Clinical Endoscopy. Published online September 22, 2026. DOI: 10.5946/ce.2026.265.
Kawas H, Beveridge C. Optimizing Bowel Preparation for Colonoscopy: Updated Consensus Recommendations. Cleveland Clinic Journal of Medicine. 2026;93(3):169–175. DOI: 10.3949/ccjm.93a.25086.
National Assembly of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15. January 9, 2023. Effective January 1, 2024, as amended where applicable.
Government of Viet Nam. Decree No. 96/2023/ND-CP, Detailing Certain Provisions of the Law on Medical Examination and Treatment. December 30, 2023, as amended where applicable.
Ministry of Health of Viet Nam. Circular No. 23/2024/TT-BYT, Promulgating the List of Medical Examination and Treatment Techniques. October 18, 2024, as amended.
Ministry of Health of Viet Nam. Circular No. 25/2026/TT-BYT, Amending and Supplementing Certain Provisions of Ministry of Health Circulars, Including Circular No. 23/2024/TT-BYT. June 30, 2026. Generally effective August 15, 2026; Articles 2 and 3 effective July 1, 2026.
Ministry of Health of Viet Nam. Consolidated Document No. 13/2026/VBHN-TT-BYT, Concerning the List of Medical Examination and Treatment Techniques. July 30, 2026.
National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15. Effective January 1, 2026.
Government of Viet Nam. Decree No. 356/2025/ND-CP, Detailing Certain Provisions and Implementation Measures of the Law on Personal Data Protection. Effective January 1, 2026.
Professional Scope and Disclaimer
This article is published by Diagnostic Excellence Vietnam (DxEx.vn), a professional initiative dedicated to advancing diagnostic quality, safety, and reliability in Viet Nam through evidence-informed knowledge sharing, risk management, measurement, and quality improvement.
The content is intended for general professional education and discussion. It does not constitute individualized medical advice, a clinical diagnostic or treatment protocol, a recommendation for patient-specific bowel preparation, colonoscopy, polypectomy, surveillance, or follow-up, a determination of professional or technical error, an accreditation assessment, certification, or legal advice.
The discussion primarily addresses diagnostic colonoscopy quality, particularly aspects relevant to colorectal neoplasia detection and prevention. Specialized therapeutic procedures, inflammatory bowel disease surveillance, hereditary cancer syndromes, pediatric colonoscopy, and other circumstances may require additional professional guidance and individualized assessment.
International quality indicators, including the performance thresholds recommended by ASGE and ACG, should be interpreted within their stated measurement populations, definitions, and limitations. They do not automatically establish legally binding performance requirements for healthcare facilities in Viet Nam.
The 2026 consensus statements developed by the Vietnam Interventional Gastroenterological Endoscopy Society represent professional guidance and should not be confused with statutory regulations issued by competent Vietnamese authorities.
The applicability of Vietnamese laws, professional requirements, and organizational obligations depends on the authorized scope of each healthcare facility and the circumstances in which services are delivered.
Patient-specific decisions regarding bowel preparation, procedural completeness, lesion assessment, histopathological evaluation, repeat colonoscopy, treatment, and surveillance must be made by appropriately qualified and authorized healthcare professionals in accordance with applicable Vietnamese law, relevant professional guidance, and individual clinical circumstances.
Diagnostic Excellence Vietnam does not provide clinical diagnosis or treatment services through this educational publication.
